Related by context. All words. (Click for frequent words.) 87 nilotinib Tasigna ® 85 imatinib Gleevec ® 84 sunitinib Sutent ® 83 erlotinib Tarceva ® 81 cetuximab Erbitux R 81 PEGylated Fab fragment 79 dasatinib Sprycel 79 TO AVOID PREGNANCY WHILE 79 refractory chronic lymphocytic 78 irinotecan doxorubicin oxaliplatin paclitaxel 78 AAG geldanamycin analog 78 bevacizumab Avastin R 78 bevacizumab Avastin ® 77 5 FU leucovorin 77 receptor tyrosine kinase inhibitor 77 CYT# potent vascular disrupting 77 alfa 2a 77 Pharmacokinetics PK 77 Meets Primary Endpoint 77 FUSILEV enhances 77 Aflibercept 77 vapreotide acetate 77 PEGylated anti 77 Ovitrelle R Serostim 77 metastatic malignant 77 oral prodrug 77 IAP inhibitor 77 FEMALES SHOULD BE ADVISED 76 R lenalidomide 76 myelodysplastic myeloproliferative diseases 76 pan histone deacetylase 76 R Saizen R 76 familial amyloidotic polyneuropathy FAP 76 virus HCV protease inhibitor 76 cutaneous T 76 PNP inhibitor 76 essential thrombocythemia ET 76 Mg Usa 76 cell lymphoma CTCL 76 lenalidomide Revlimid R 76 PRN FDA Approves 76 Navelbine ® 76 Bosutinib 76 Xeloda ® 76 metastatic castration resistant 76 advanced metastatic renal 76 BCG refractory carcinoma 76 liposomal formulation 75 novel VDA molecule 75 Irinotecan 75 ribavirin RBV 75 imatinib resistant 75 refractory chronic myeloid 75 AVASTIN 75 cetuximab Erbitux ® 75 developing Bicifadine serotonin 75 VEGFR2 inhibitor 75 leukemia AML 75 IgG1 monoclonal antibody 75 irinotecan containing 75 SPRYCEL ® 75 Peginterferon Alfa 2a 75 chronic eosinophilic leukemia 75 2 methoxyestradiol 75 MKC# MT 75 plus prednisone prednisolone 75 erlotinib Tarceva R 75 D aspartate NMDA receptor 75 monoclonal antibody IgG1 Mab 75 anthracycline taxane 75 Zorbtive TM 75 TNF Tumor Necrosis Factor 75 oral nucleoside analogue 75 Peginterferon 75 interferon beta 1a infertility 75 Annamycin 75 refractory NSCLC 75 carcinoma mCRC 75 evaluating picoplatin 75 CYP#A# CYP#D# 75 antibody MAb 75 sodium glucose cotransporter 75 itraconazole Sporanox 75 docetaxel Taxotere ® 75 ® lenalidomide 75 adalimumab Humira 75 thalidomide Thalomid 75 pralatrexate injection folate analogue 75 brand ciclesonide HFA 74 tumors GIST 74 MAGE A3 ASCI 74 Vidaza ® 74 Paraplatin ® 74 Complicated Skin 74 R roscovitine CDK cyclin 74 relapsed refractory multiple myeloma 74 dexamethasone Decadron 74 recurrent glioblastoma multiforme 74 multi kinase inhibitor 74 orally administered inhibitor 74 alpha 2b 74 topical gel formulation 74 trastuzumab Herceptin R 74 Cutaneous T 74 Dementia Related Psychosis 74 XL# anticancer compounds 74 alpha folate receptor 74 sorafenib Nexavar 74 ADP receptor antagonist 74 Hormone Refractory Prostate Cancer 74 Tezampanel 74 cisplatin gemcitabine 74 Phase IIb Trial 74 refractory cutaneous T 74 sorafenib tablets 74 PEGINTRON TM 74 beta 1a 74 Oral Fingolimod 74 Crofelemer budesonide foam 74 hypertrichosis occurred 74 polymerase inhibitor 74 Copegus ® 74 IMiDs ® 74 Serostim ® 74 gemcitabine cisplatin 74 modified glutathione analog 74 evaluating tivozanib 74 Trial Evaluating 74 investigational pharmacologically unique 74 5 fluorouracil leucovorin 74 Coadministration 74 dependent kinase inhibitor 74 R metformin Concor 74 Phase 2b Clinical Trial 74 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 73 lexidronam injection 73 targeted radiotherapeutic 73 Mg Uk 73 LymphoStat B belimumab 73 metastatic GIST 73 Fludarabine 73 metastatic colorectal 73 myelofibrosis polycythemia vera 73 GW# [003] 73 investigational humanized monoclonal antibody 73 Personalized Immunotherapy 73 Adjuvant Treatment 73 Pegloticase 73 alkylating agent 73 Combination REOLYSIN R 73 Study Evaluating 73 oral proteasome inhibitor 73 docetaxel Taxotere 73 PegIFN 73 Peginterferon alfa 2b 73 gefitinib Iressa 73 arsenic trioxide injection 73 intravesical infusion therapy 73 Vidaza R 73 Camptosar ® 73 PROCTOCORT R 73 Telik logo TELINTRA 73 Relapsed Refractory 73 ara C 73 pegylated interferon alfa 2a 73 Myelodysplastic Syndrome MDS 73 Pegasys ® 73 Albuferon TM 73 Vascular Disrupting Agent 73 cyclophosphamide chemotherapy 73 adriamycin 73 histone deacetylase HDAC inhibitor 73 generation purine nucleoside 73 Phase 2b Trial 73 oropharyngeal candidiasis OPC 73 systemic anaplastic large 73 hypereosinophilic syndrome 73 Naive Patients 73 Epothilone D 73 methylnaltrexone bromide 73 investigational oral inhibitor 73 Initiate Phase 73 Cloretazine ® 73 gemcitabine Gemzar ® 73 ALN HPN 73 relapsed MM 73 Kit CD# positive 73 temsirolimus Torisel 73 TRANSDUR ® 73 Severe Sepsis 73 lintuzumab SGN 73 INVANZ 73 product candidate Lpathomab 73 Copegus ribavirin 73 Aurora Kinase 73 Amgen Neulasta R 73 Fludara ® 73 sapropterin dihydrochloride 73 gastrointestinal stromal tumors GIST 73 dacarbazine DTIC 73 Myelofibrosis 73 oral dual endothelin 73 mapatumumab 73 prostate cancer HRPC 73 ergot derivatives 73 Dose Ranging Study 73 CYP#A# substrate 73 echinocandin 73 FOLFOX6 73 Belimumab 73 HGS ETR1 mapatumumab 73 non nucleoside inhibitor 73 leukemia CLL 73 By JENNIFER LEARN 73 Interferon alfa 2b 73 Romiplostim 73 Panzem R 73 bortezomib Velcade R 73 Completes Patient Enrollment 73 memantine HCl 73 Pruvel TM 73 refractory gout 72 Refractory Hodgkin Lymphoma 72 triggers apoptosis programmed 72 potent CYP#A# inhibitors 72 Kinase Inhibitor 72 agonistic human 72 FUSILEV ® 72 dihydrochloride 72 cell carcinoma RCC 72 IMiDs R 72 metaglidasen 72 hormone LHRH antagonist 72 Xyfid TM 72 NS5B polymerase 72 mRCC 72 substantially excreted 72 docetaxel Taxotere R 72 Solution XOPENEX HFA 72 Lenocta TM 72 CDK cyclin dependent 72 Investigational Oral 72 COPEGUS R 72 SinuNase TM 72 humanized interleukin 6 72 Chronic Hepatitis C 72 Omacetaxine 72 Azacitidine 72 FDA APPROVES 72 Plaque Psoriasis 72 metastatic renal cell carcinoma 72 gemcitabine Gemzar 72 Epratuzumab 72 antiangiogenesis therapies 72 inflammatory PDE 72 Tipranavir 72 pegylated interferon alpha 72 formerly LymphoStat B 72 vinca alkaloid 72 sarcoma melanoma 72 CD4 monoclonal antibody 72 Initiates Enrollment 72 Hsp# Inhibitor 72 pan HDAC inhibitor 72 Mylan Receives Approval 72 Pemetrexed 72 R bisoprolol Euthyrox 72 situ CIS 72 dihydrochloride Tablets 72 R memantine HCl 72 dextromethorphan quinidine 72 Doxil ® 72 TLK# 72 Mycophenolate Mofetil 72 proteasome inhibitor 72 non splenectomized 72 Cannabinor 72 RON Notch 72 cyclophosphamide methotrexate 72 imatinib Gleevec 72 Suppository Hydrocortisone Acetate Rectal 72 generation Hsp# inhibitor 72 Novel Oral 72 topically applied SEPA 72 Bortezomib 72 metastatic hormone refractory 72 documented candidiasis 72 Receives Orphan Drug Designation 72 delivers fluocinolone acetonide FA 72 Gemzar ® 72 abacavir sulfate lamivudine 72 Diffuse Large B 72 TKB# 72 Phase 2a Clinical Trial 72 Factor Receptor 72 nilotinib Tasigna 72 Advanced Renal Cell 72 PDX pralatrexate 72 Granted Orphan Drug 72 MEK Inhibitor 72 tyrosine kinase inhibitor TKI 72 EGFR expressing mCRC 72 Obatoclax 72 oral dihydropyrimidine dehydrogenase DPD 72 Cyclooxygenase Inhibiting Nitric Oxide 72 IMiDs ® compound 72 Sapacitabine 72 castrate resistant prostate cancer 72 5 Fluorouracil 72 Gel repository corticotropin injection 72 candidates Azedra TM 72 HER2 positive metastatic breast 72 interferon gamma 1b 72 Sudhir Agrawal D.Phil 72 Wafer polifeprosan 72 rHuPH# recombinant human 72 Dasatinib 72 Talabostat 72 BUPHENYL R sodium phenylbutyrate 72 luteinizing hormone releasing 72 NOTE POSIDUR ™ 72 panitumumab Vectibix R 72 pertuzumab 72 unique alkylating agent 72 ZOLINZA 72 phase III isavuconazole 72 MyVax R 72 psoriasis rheumatoid arthritis 72 cardiometabolic diseases Glucophage 72 peptidic compound 72 Atripla combines 71 Known hypersensitivity 71 selective antagonist 71 Loceryl ® 71 acetonide FA 71 Inhalation Aerosol 71 sunitinib Sutent 71 ACTEMRA TM 71 novel histone deacetylase 71 ribavirin therapy 71 Pafuramidine 71 HCV NS5B polymerase 71 etanercept Enbrel 71 indinavir Crixivan 71 humanised monoclonal antibody 71 IN PATIENTS WITH 71 OMP #R# 71 Orally administered 71 CTAP# Capsules 71 Randomized Phase 71 apoptosis proteins 71 Degarelix 71 FOLOTYN ® 71 VELCADE melphalan 71 selective modulator 71 Panzem R NCD 71 8mg/kg 71 DNA methyltransferase inhibitors 71 Tarceva TM 71 RhuDex TM 71 included exfoliative dermatitis 71 vinca alkaloids 71 hyperplasia BPH 71 small molecule Hedgehog 71 mu opioid receptor antagonist 71 ALVESCO ® 71 Methylnaltrexone 71 alpha 2a 71 alefacept 71 potent triglyceride lowering 71 estrogen receptor antagonist 71 DOXIL 71 refractory AML 71 including cyclosporine methotrexate 71 non peptidic protease 71 FOLFOX6 chemotherapy regimen 71 triciribine phosphate monohydrate 71 relapsed multiple myeloma 71 TRIOLEX HE# APOPTONE HE# 71 Budesonide foam crofelemer 71 Traficet EN 71 PKC# 71 Daclizumab 71 biologic DMARD 71 Glufosfamide 71 PROCTOCORT ® Suppository Hydrocortisone 71 evaluating Xcytrin 71 refractory multiple myeloma 71 Previously Treated 71 novel emulsion formulation 71 administered concomitantly 71 Serostim R 71 ritonavir boosted 71 Neulasta R 71 Luveris R Ovidrel R 71 metformin HCl 71 Cream Hydrocortisone Cream USP 71 investigational antiplatelet agent 71 herpetic keratitis 71 Soft Tissue Sarcoma 71 peripherally acting 71 HGS ETR2 71 overactive bladder VANTAS 71 reversible inhibitor 71 alvespimycin 71 paclitaxel Taxol ® 71 assessing T DM1 71 Epidermal Growth Factor Receptor 71 iobenguane 71 resistant hormone refractory 71 IV FENTORA R 71 R sorafenib tablets 71 selective A2A adenosine receptor 71 5 FU capecitabine 71 Drug Candidate 71 somatostatin analogue 71 Phase #b/#a clinical 71 paclitaxel Taxol 71 Pivotal Phase III 71 stage IIIB 71 Mitoxantrone 71 liposomal doxorubicin 71 xanthine oxidase inhibitor 71 events thrombocytopenia neutropenia 71 mTOR inhibitor 71 5q MDS 71 Prolongs Survival 71 personalized cellular immunotherapy 71 ENL recurrence 71 Peginterferon alfa 2a 71 rheumatoid arthritis RA psoriatic 71 mitoxantrone plus 71 5 HT2A inverse 71 Acetate Rectal Suppositories 71 Hydrochlorothiazide Tablets 71 recurrent NSCLC 71 Xanafide 71 LymphoStat B TM 71 Aztreonam lysine 71 gastrointestinal stromal tumor GIST 71 AN# topical anti 71 estramustine 71 basiliximab 71 Amrubicin 71 Investigational Treatment 71 non thiazolidinedione TZD 71 EGFR TKI 71 phenyl salicylate methylene blue 71 Patients Treated With 71 M2 subunit 71 neutropenia dehydration dyspnea 71 hypoxia activated prodrug 71 mGluR5 negative 71 Ribavirin causes 71 carbamazepine phenobarbital phenytoin rifampin 71 First Patient Dosed 71 Ixempra 71 abacavir lamivudine 71 ACTIQ ® 71 accumulate preferentially 71 including eniluracil ADH 71 HSP# inhibitor 71 influenza BCX# purine nucleoside 71 particularly SANCTURA XR 71 telomerase therapeutic 71 INSPIRE Trial Phase III 71 Emtriva Viread 71 Submits NDA 71 Panzem NCD 71 targeted antifolate 71 kidney urologic 71 nucleoside analog 71 ERBITUX cetuximab 71 bucindolol hydrochloride 71 ALN PCS 71 superficial basal cell carcinoma 71 vinorelbine tartrate 70 docetaxel chemotherapy 70 stage IIIb IV 70 Metastatic Melanoma 70 irreversible inhibitor 70 Gleevec resistant 70 2 inhibitor CYT# 70 Cyclophosphamide 70 Neoadjuvant 70 galiximab 70 toenail onychomycosis 70 catheter occlusion 70 R brand levalbuterol 70 orally inhaled migraine 70 benzoic acid hyoscyamine sulfate 70 R bendamustine hydrochloride 70 Demonstrates Positive 70 R rilonacept Injection 70 markets COLAZAL 70 humanized therapeutic 70 Romidepsin 70 idarubicin 70 HuCAL PLATINUM ® CysDisplay 70 % pramoxine HCl 70 Ofatumumab 70 5 HT3 antagonist 70 immunomodulatory therapy 70 evaluating T DM1 70 peginterferon alfa 2a Pegasys 70 Blinatumomab 70 denileukin diftitox 70 receiving INTRON 70 Acute Myeloid Leukemia AML 70 Tibotec Therapeutics division 70 Relapsed Refractory Multiple Myeloma 70 radiation sensitizer 70 sorafenib Nexavar ® 70 Darinaparsin 70 demonstrated antitumor activity 70 TELINTRA 70 Voreloxin 70 humanized anti 70 diarrhea predominant irritable 70 Lenalidomide 70 CYT# vascular disrupting 70 reversible inhibitors 70 primary hypercholesterolemia 70 metastatic castrate resistant 70 EPIVIR 70 Initiates Clinical Trial 70 selective phosphodiesterase 70 Castration Resistant Prostate Cancer 70 Phase IIb Clinical Trial 70 erlotinib Tarceva 70 Initiates Phase II 70 metastatic pancreatic 70 voriconazole 70 Vitrasert R 70 methylergonovine 70 Sodium oxybate 70 N acetylgalactosamine 6 70 Monotherapy 70 Epivir R 70 infliximab monotherapy 70 Gonal f R 70 MGd 70 markets HP Acthar 70 VANOS TM fluocinonide Cream 70 oncolytic virus therapies 70 chemosensitizer 70 Anti Tumor 70 superficial bladder cancer 70 4mg/kg 70 Ozarelix 70 cortisol synthesis 70 Philadelphia Chromosome Positive 70 infectious diseases autoimmune diseases 70 Cytarabine 70 PANVAC VF 70 pediatric Crohn disease 70 Ovidrel 70 diarrhea fatigue asthenia 70 Previously Untreated 70 Bezielle 70 DEB# 70 Elotuzumab 70 Acute Attacks 70 pegylated liposomal doxorubicin 70 elotuzumab 70 recurrent metastatic ovarian cancer 70 IMiDs 70 cytidine nucleoside analog 70 Platinol ® 70 panitumumab Vectibix 70 Clolar ® 70 substrates inhibitors 70 * olmesartan medoxomil 70 HYVISC ® treatment 70 PRT# 70 XL# XL# 70 investigational monoclonal antibody 70 Pivotal Phase 70 Ecallantide 70 WX UK1 70 YONDELIS 70 ALVESCO R 70 somatropin Kuvan R 70 Initiate Clinical Trial 70 refractory Hodgkin lymphoma 70 PEG interferon 70 tyrosine kinase inhibitors TKIs 70 sodium thiosulfate STS 70 Nilotinib 70 opioid induced constipation OIC 70 aflibercept VEGF Trap 70 Files IND 70 clinical trials Archexin ® 70 monoclonal antibody conjugated 70 Hycamtin ® 70 Vicinium TM 70 BENLYSTA TM 70 paclitaxel Taxol R 70 alkylating 70 Interferon beta 1a 70 AKT inhibitor 70 Nitazoxanide 70 ATRA IV 70 EGFR HER2 70 Ranolazine 70 Carfilzomib 70 Announces Tentative Approval 70 neuropathic pain metabolic diseases 70 soluble tumor necrosis 70 KRN# 70 oral rivaroxaban 70 huN# DM1 70 HMG CoA reductase inhibitors 70 non porcine pancreatic 70 Peg IFN 70 Recombinant Human 70 Well Tolerated 70 tazobactam 70 vaginal candidiasis 70 arthritis PsA 70 anthracycline containing 70 EOquin TM phase 70 inhibits dihydrofolate reductase 70 inhalation aerosol 70 dacarbazine 70 Medoxomil 70 Fulvestrant 70 RhuDex R 70 Polymerase Inhibitor 70 immune idiopathic thrombocytopenic 70 Phase Ib clinical trials 70 metabolic disorders Saizen R 70 systemic fungal infections 70 CHEAP ONLINE PHARMACY LOW 70 JAK2 Inhibitor 70 Maribavir 70 Monopril 70 K ras mutations 70 SinuNase ™ 70 Atypical Hemolytic Uremic Syndrome 70 steroid refractory ulcerative 70 purpura ITP 70 ALN TTR 70 NASH Huntington 70 dual PPAR peroxisome 70 ceftazidime 70 peripherally restricted 70 CIMZIA TM 70 aripiprazole Abilify 70 CYP#A# isoenzyme 70 unresectable Stage III 70 TRANSDUR ™ 70 Melphalan 70 PEG IFN 70 Silodosin 70 Ondansetron Injection USP 70 atypical Hemolytic Uremic Syndrome 70 Staphylococcus aureus Immune Globulin 70 Nebulized 70 novel synthetic PEGylated 70 IL# PE#QQR 70 systemic RNAi therapeutic 70 Remicade infliximab 70 inhalation powder 70 anthracyclines taxanes 70 Receives Fast Track 70 II Clinical Trial 70 IMPDH inhibitor 70 Oral Suspension Oral Suspension 69 See CONTRAINDICATIONS 69 EGFr expressing metastatic colorectal 69 nucleotide analogue 69 EGFR tyrosine kinase inhibitor 69 receptor modulators 69 subtype selective NMDA receptor 69 FOLFOX chemotherapy 69 Eculizumab 69 J Am Acad 69 CLL SLL 69 visilizumab 69 cutaneous T cell 69 plus prednisone 69 vesicular monoamine transporter 69 octreotide acetate 69 RhuDex ® 69 Dapagliflozin 69 Host Disease 69 capecitabine Xeloda 69 Clevudine 69 alpha interferons 69 Ostarine ™ 69 beclomethasone dipropionate 69 delayed onset CINV 69 Ph + acute lymphoblastic 69 immunomodulating 69 Enzastaurin 69 antibody MT# 69 brivanib 69 adenosine injection 69 Inhalation Solution 69 Preclinical Data 69 sunitinib malate 69 Decitabine 69 Hemispherx flagship products 69 mertansine 69 Temsirolimus 69 myocardial infarction ventricular fibrillation 69 Luteinizing Hormone Releasing Hormone 69 Rigel R# 69 AMMONUL R sodium phenylacetate 69 TAFA# 69 RANK Ligand inhibitor 69 forodesine 69 Tyrosine Kinase Inhibitor 69 investigational immunotherapy 69 indolent follicular non 69 MKC# MKC# PP 69 Oracea TM 69 Completes Enrollment 69 class anticancer quinolone 69 ORENCIA ® 69 white petrolatum Ointment 69 Janus kinase 69 Simulect 69 FOLFIRI 69 receiving prophylactic anticoagulation 69 refractory indolent non 69 acute GvHD 69 alkylating agents 69 Sprycel dasatinib 69 q#h 69 Gleevec imatinib mesylate 69 Metastatic Colorectal Cancer 69 Bevacizumab 69 Treated Patients 69 DURECT proprietary 69 known dihydropyrimidine dehydrogenase 69 relapsed leukemia 69 refractory acute myeloid 69 polycythemia vera essential thrombocythemia 69 highly selective endothelin 69 novel topoisomerase 69 chlorambucil 69 metastatic androgen independent 69 temsirolimus 69 Phase 1b clinical trials 69 Initiate Phase III 69 Cloretazine 69 HDAC Inhibitor 69 HBeAg positive patients 69 lamotrigine Lamictal 69 ® decitabine 69 Kinesin Spindle Protein KSP 69 ocular formulation 69 Ziprasidone 69 Initiates Phase III 69 Navelbine 69 severe hypersensitivity reactions 69 5 HT4 69 Soriatane 69 delta gamma agonist 69 plasma kallikrein inhibitor 69 Liposomal 69 J Am Coll 69 Velcade bortezomib 69 Anthracycline 69 TELCYTA 69 Granulocyte Colony Stimulating Factor 69 trastuzumab Herceptin ® 69 fludarabine 69 Humanized Anti 69 highly selective inhibitor 69 balsalazide disodium Capsules 69 protein kinase inhibitor 69 certain protein tyrosine 69 TO TREAT 69 miconazole Lauriad ® 69 interferon alfa 2a 69 CTA# Injection 69 human rDNA origin 69 highly purified pasteurized 69 certolizumab 69 plus DOXIL 69 selective kinase inhibitor 69 Phase 2b Study 69 bone marrow reticulin deposition 69 gastrointestinal stromal 69 HGS ETR1 69 lucinactant 69 Adjunctive Therapy 69 Lymphocytic 69 Alfacell proprietary ribonuclease 69 temsirolimus Torisel ® 69 pharmacologically active isomer 69 ODT metoclopramide HCl PEPCID 69 TLR9 agonist 69 IMA# 69 leukotriene receptor antagonist 69 ® EBLY ® MASTERFOODS 69 Elagolix 69 mitogen activated ERK kinase 69 AEG# 69 diaper dermatitis complicated 69 subcutaneous formulation 69 hormone refractory metastatic prostate 69 BiovaxID TM 69 ribavirin Copegus ® 69 Seliciclib CYC# 69 Antitumor Activity 69 trabectedin 69 non alcoholic steatohepatitis 69 MT# MEDI 69 Tasigna nilotinib 69 cisplatin carboplatin 69 Phase 2a Trial 69 CCX# B 69 TNF alpha selectively neutralizing 69 signal transduction inhibitor 69 rALLy clinical trial 69 pegylated interferons 69 metastatic carcinoid 69 BY ROB WEILER 69 trimethoprim sulfamethoxazole 69 HCD# [002] 69 oxaliplatin Eloxatin 69 Navelbine R 69 Laquinimod 69 CD# monoclonal antibody 69 abatacept Orencia 69 label Lipofen R 69 Anti VEGF 69 milnacipran HCl 69 Pazopanib 69 IV Busulfex 69 posaconazole 69 Phase III Pivotal 69 interferon alfa 2b 69 II TRISENOX R 69 Newly Diagnosed Multiple Myeloma 69 Piperacillin 69 anticancer compound 69 Flu Cy 69 HGS# 69 Vandetanib 69 NicVAX TM 69 Quinamed 69 Cetuximab Erbitux 69 erythematosus 69 dasatinib 69 AVONEX ® 69 hematological cancers notably 69 Pegylated Interferon 69 Intravenous Human 69 BUPHENYL ® sodium phenylbutyrate 69 oral ridaforolimus 69 aplastic anemia AA 69 administered subcutaneously 69 hepatitis C HCV 69 NU# direct 69 oral vancomycin 69 #mg BID [003] 69 Initiates Phase 69 Copegus R 69 Liprotamase 69 KSP inhibitor 69 standard chemotherapy regimen 69 candesartan cilexetil 69 metastatic colorectal carcinoma 69 REVLIMID R 69 following fluoropyrimidine oxaliplatin 69 ganetespib 69 TELINTRA R 69 PEGASYS ® 69 nilotinib 69 dopamine receptor agonist 69 MetroGel 69 ELADUR TM 69 small molecule tyrosine 69 Pegylated 69 mild vasodilator 69 hyperphenylalaninemia HPA due 69 HCl PEPCID ® famotidine 69 Plus Ribavirin 69 Demonstrated Significant 69 tenofovir disoproxil fumarate Viread 69 non resectable 69 R chorionic gonadotropin 69 Refractory Peripheral T 69 Aptivus ® 69 mTOR mammalian target 69 IAP inhibitors 69 antimetabolite 69 VISICOL R 69 paclitaxel cisplatin 69 XOMA 3AB biodefense 69 Onalta ™ 69 reslizumab 69 Adalimumab 69 nucleoside reverse transcriptase inhibitor 69 sodium benzoate prescription 69 Solazed TM 69 First Patient Enrolled 69 intravenously administered 69 agent VDA 69 drug pipeline TAFA# 69 milnacipran HCI 69 Iluvien ® 69 TRIAL OF 69 tyrosine kinase inhibitor 69 treat chronic sinusitis 69 q8h 69 DORIBAX 69 Archexin 69 HCV RNA polymerase 69 sapropterin dihydrochloride Tablets 69 R fluocinolone acetonide 69 PEGylated interferon beta 1a 69 Imatinib mesylate 69 tumor activated prodrug 69 colesevelam HCl 69 somatostatin analog 69 Tumor Necrosis Factor 69 T#I [002] 69 ELADUR ™ 69 imatinib mesylate 69 de novo kidney transplant 69 Lupus Nephritis 69 Cardium Therapeutics TM 69 Begins Dosing 69 Valopicitabine 69 Phase IIa Clinical Trial 69 mg qd 69 CCR9 antagonist 69 unresectable locally advanced 69 unresectable stage 69 allosteric modulator NAM 69 severe neutropenia 69 Ophena TM 69 acyclovir Lauriad R 69 serologically active systemic lupus 69 including thyroiditis RA 69 anti amnesic 69 saline placebo 69 Vicriviroc 69 Crizotinib PF # 69 novel tubulin binding 69 plus dexamethasone 69 Relapsed 69 intranasal formulation 69 Friedreich Ataxia FRDA 69 selective inhibitor 69 valsartan amlodipine 69 SUPPRELIN R LA 69 histone deacetylase inhibitor 69 MCSP respectively 69 5 lipoxygenase inhibitor 69 PegIFN RBV 69 CB2 selective receptor agonist 69 Noxafil 68 HCV polymerase inhibitors 68 Perifosine KRX 68 R brand arformoterol 68 induced macular edema 68 huC# DM4 68 Saizen ® 68 investigational protease inhibitor 68 nanofiltered plasma derived 68 NS5b 68 lymphoid malignancies 68 oral Janus kinase 68 Therapy RecoveryRx TM 68 BY STEPHANIE A. WILKEN 68 Primary Hypercholesterolemia 68 metabolic alkalosis 68 Taxotere ® 68 plus dacarbazine 68 lymphoma CTCL 68 PROCTOCORT R Suppository Hydrocortisone 68 include Phenoptin TM 68 Pharma Merck Serono 68 REPRONEX R menotropins 68 anti atherothrombotic 68 NDA Submission 68 R abacavir sulfate 68 Altera Nebulizer System 68 mitomycin 68 Trastuzumab 68 infectious diseases autoimmune 68 bortezomib Velcade 68 Disease IBD 68 melphalan prednisone 68 small molecule chemotherapeutic 68 Ceflatonin R 68 Kamada AAT 68 AVAPRO 68 NEBIDO VANTAS SUPPRELIN LA 68 intravesical instillation 68 fluocinonide Cream 68 Levofloxacin